Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1997-08-08
2000-02-15
Woodward, Michael P.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
530356, 435212, 435273, A61K 3839, C07K 1478
Patent
active
060253274
ABSTRACT:
Hydrolyzed collagen type II powder compositions, method of preparing the compositions and use of the compositions in treating cartilage defects. The compositions are orally administered to an individual in need of cartilage augmentation in a daily dosage of between about 2,000 and 3,000 mg per day.
REFERENCES:
patent: 4511653 (1985-04-01), Play et al.
patent: 4804745 (1989-02-01), Koepff et al.
patent: 5206023 (1993-04-01), Hunziker et al.
patent: 5364775 (1994-11-01), Katsumata et al.
patent: 5364845 (1994-11-01), Henderson
patent: 5399347 (1995-03-01), Trentham et al.
patent: 5587363 (1996-12-01), Henderson
patent: 5645851 (1997-07-01), Moore
Darnell et al. Molecular Cell Biology. Scientific American Books, Inc. New York, NY, 1986.
Fawcett. A Textbook of Histology. W. B. Saunders Co. Philadelphia, PA, 1986.
Product Advertisement for Hydrolyzed Collagen Beauty Supplement Smarter Nails & Hair, Inc., 1987.
Knauper et al. Biochemical characterization of human collagenase-3. J. Biol. Chem. 271:1544-1550, Jan. 19, 1996.
Bedi et al. Purification and characterization of a collagen-degrading protease from Porphyromonas ginivalis. J. Biol. Chem. 269:599-606, Jan. 7, 1994.
M. Barinaga, "Treating Arthritis With Tolerance," Science 261:1669-1670 (1993).
M.A. Cremer, et al., "Collagen-Induced Arthritis In Rats: Antigen-Specific Suppression of Arthritis and Immunity By Intravenously Injected Native Type II Collagen," The Jour. of Immun. 131(6)2995-3000 (1983).
M.E. Englert, et al., "Suppression of Type II Collagen-Induced Arthritis by the Intravenous Administration of Type II Collagen or Its Constituent Peptide .alpha..sub.1 (II) CB.sub.10, " Cellular Immunology 87:357-365 (1984).
New Product Advertisement for "Hydrolyzed Collagen Beauty Supplement.TM." Smarter Nails & Hair, Inc., Newport Beach, CA 92660 (1987).
L. Stryer, "Collagen Has An Unusual Amino Acid Composition And Sequence," Biochemistry, Third Edition, W.H. Freeman and Co., New York, p. 262 (1988).
D.E. Trentham, et al., "Autoimmunity to Type II Collagen: An Experimental Model of Arthritis," The Journal of Experimental Medicine 146:857-868 (1977).
D.E. Trentham, et al., "Effects of Oral Administration of Type II Collagen on Rheumatoid Arthritis," Science 261:1727-1730 (1993).
Brucknet et al. `p-HMW-Collagen, a minor collgen obtained form chick embryo cartilage without proteolytic treatment of the tissue`, Eur. J. Biochem. vol. 136, pp. 333-339, 1983.
File Caplus on STN. No. 1984:180121. RO 80226, Nov. 30, 1982. Abstract only, 1984.
Trentham et al. `Autoimmunity of Type II Collagen: An Experimental Model of Arthritis`, J. of Exp. Mdicine. vol. 146, pp. 857-868, 1977.
Biocell Technology, LLC
Gupta Anish
Woodward Michael P.
LandOfFree
Hydrolyzed collagen type II and use thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hydrolyzed collagen type II and use thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hydrolyzed collagen type II and use thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1905932